Log in to search using one of your social media accounts:

 

Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa ® than with warfarin
Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa ® than with warfarin (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

ESC Congress 2014 Hot Line Session: Favourable effect of Pradaxa ® on kidney function over time compared to warfarin
ESC Congress 2014 Hot Line Session: Favourable effect of Pradaxa ® on kidney function over time compared to warfarin (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

Treatment with Pradaxa ® associated with better patient outcomes after a major bleeding event compared to warfarin
Treatment with Pradaxa ® associated with better patient outcomes after a major bleeding event compared to warfarin (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

Better outcome in case of major bleed for patients taking the anticoagulant Pradaxa ® compared to warfarin
Better outcome in case of major bleed for patients taking the anticoagulant Pradaxa ® compared to warfarin (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

Pradaxa ® (dabigatran etexilate) 150mg bid continues to be the only oral anticoagulant which showed superior ischaemic stroke reduction vs. warfarin in its pivotal study RE-LY® – Results of the ENGAGE AF-TIMI 48 trial published for edoxaban vs. warfarin do
Pradaxa ® (dabigatran etexilate) 150mg bid continues to be the only oral anticoagulant which showed superior ischaemic stroke reduction vs. warfarin in its pivotal study RE-LY® – Results of the ENGAGE AF-TIMI 48 trial published for edoxaban vs. warfarin do (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

NOACs Show Lower Risk of Adverse Renal Outcomes in A - Fib
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 21, 2017 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

Clinical outcomes and history of fall in patients with atrial fibrillation treated with oral anticoagulation: insights from the ARISTOTLE Trial - Rao MP, Vinereanu D, Wojdyla DM, Alexander JH, Atar D, Hylek EM, Hanna M, Wallentin L, Lopes RD, Gersh BJ, Granger CB.
PURPOSE: We assessed outcomes among anticoagulated patients with atrial fibrillation (AF) and a history of falling, and whether the benefits of apixaban versus warfarin are consistent in this population. METHODS: Of the 18,201 patients in ARISTOTLE... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Warfarin Linked to Lower Cancer Risk Warfarin Linked to Lower Cancer Risk
A large observational study finds a lower incidence of cancer in warfarin users, which could have important implications for the selection of medications for patients needing anticoagulation, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Warfarin Use Tied to Lower Cancer Risk
Use of warfarin is associated with reduced incidence of cancer among older adults, according to an observational study in JAMA Internal Medicine. Using Norwegian registries... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 9, 2017 Category: Primary Care Source Type: news

Speed makes a difference when using clot-stabilising drug in severe bleeding
Immediate treatment with clot-stabilising drug can reduce risk of death due to blood loss by 70% Related items fromOnMedica Heavy menstrual bleeding Bleeding risk with long-term aspirin increases substantially with age Direct oral anticoagulants as safe as warfarin after VTE Include pregnant women in studies, urge researchers (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 8, 2017 Category: UK Health Source Type: news

Warfarin Use Tied to Lower Cancer Risk (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Use of warfarin is associated with reduced incidence of cancer among older adults, according to an observational study in JAMA Internal … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 7, 2017 Category: Primary Care Source Type: news

Lower risk of several cancers in people taking warfarin
Lower cancer incidence across a broad range of malignant neoplasms in people older than 50 (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 7, 2017 Category: UK Health Source Type: news

Medical News Today: Warfarin may prevent cancer
The anticoagulant warfarin may do more than prevent blood clots. Researchers have found that the drug may also protect against cancer development. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 6, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Blood thinning drugs lower the risk of cancers by 30%
Norwegian researchers have found warfarin was linked with lower risk of any cancer and of three of the most common cancers, prostate, lung, and breast but not bowel cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 6, 2017 Category: Consumer Health News Source Type: news

Cancer news: THIS common blood thinner linked to lower risk of THREE deadly types
CANCER remains a deadly condition globally, but a common medication - warfarin - has been linked to reduced risk of prostate, breast and lung types. (Source: Daily Express - Health)
Source: Daily Express - Health - November 6, 2017 Category: Consumer Health News Source Type: news

Could a Common Blood Thinner Lower Cancer Risk?
MONDAY, Nov. 6, 2017 -- A pill widely taken to prevent heart attack and stroke may also guard against cancer, new research suggests. Warfarin is an inexpensive blood thinner. It's typically prescribed for patients whose leg arteries are prone to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 6, 2017 Category: General Medicine Source Type: news

Is anticoagulant warfarin associated with lower risk of cancer incidence?
(The JAMA Network Journals) Bottom Line: Use of the blood thinner warfarin was associated with a lower risk of new cancers in people over 50. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 6, 2017 Category: Cancer & Oncology Source Type: news

TCT 2017: Boston Scientific touts lowered hemorrhagic stroke rate, cost for patients in Watchman studies
Boston Scientific (NYSE:BSX) today released combined 5-year outcomes data from both the Prevail and Protect-AF study of its Watchman left atrial appendage closure device, touting it as a safe and effective an alternative to long-term warfarin therapy for patients with non-valvular atrial fibrillation. Five-year data from the Prevail study was published online today in the Journal of the American College of Cardiology. In both trials, the Marlborough, Mass.-based company compared the Watchman device to warfarin treatment for stroke prevention in patients with non-valvular AF with follow-ups out to five years. A combine...
Source: Mass Device - November 2, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Boston Scientific Source Type: news

Blood-thinning drugs may reduce dementia risk in people with irregular heartbeats
Conclusion If you’ve been diagnosed with AF and you have been prescribed anticoagulant treatments such as warfarin or clopidogrel, we already know they protect you against having a stroke. This study suggests they may also help to protect you against dementia. Cutting the risk of dementia for people who have a raised risk because of AF would be an exciting step forward. Unfortunately, we can’t tell from this study whether the protection against dementia was down to the anticoagulants, because of the possible effect of unmeasured confounding factors. Usually, we would want to see a randomised controlled trial (R...
Source: NHS News Feed - October 25, 2017 Category: Consumer Health News Tags: Neurology Source Type: news

Dementia Less Likely With Oral Anticoagulants for Afib
(MedPage Today) -- Similar effect observed with NOACs, warfarin in Swedish registry data (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 25, 2017 Category: Psychiatry Source Type: news

Dementia news: Blood thinning drugs like warfarin 'could protect against dementia'
COMMON blood thinning drugs like warfarin have the power to protect against dementia, new research suggests. (Source: Daily Express - Health)
Source: Daily Express - Health - October 25, 2017 Category: Consumer Health News Source Type: news

New Dementia breakthrough: Blood-thinning drugs slash risk of being struck down
COMMON blood thinning drugs like warfarin have the power to protect against dementia, new research suggests. (Source: Daily Express - Health)
Source: Daily Express - Health - October 24, 2017 Category: Consumer Health News Source Type: news

Genetic testing helps determine safest dose of blood thinner for joint surgery patients
(Intermountain Medical Center) A new five-year study of nearly 1,600 patients finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer side effects, in patients undergoing joint replacement surgery. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 23, 2017 Category: Biology Source Type: news

Real-World Reassurance on Bleeding Risk With DOACs in VTE Real-World Reassurance on Bleeding Risk With DOACs in VTE
A new observational study found that the new direct oral anticoagulants are not associated with increased risk for major bleeding or all-cause mortality compared with warfarin in the first 3 months of treatment.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 19, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Newer Blood Thinners Don't Raise Bleeding Risk
Risk is similar to warfarin, study reports (Source: WebMD Health)
Source: WebMD Health - October 18, 2017 Category: Consumer Health News Source Type: news

Despite 'bad press,' new blood thinners aren't linked to greater bleeding risk: Study
New anti-clotting drugs -- like Xarelto, Pradaxa and Eliquis -- aren't linked with a higher risk of bleeding than the older drug warfarin, a new study finds (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 18, 2017 Category: Consumer Health News Source Type: news

Newer Blood Thinners May Not Bring Higher Bleeding Risk
Risk is similar to warfarin, study reports Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Blood Thinners, Deep Vein Thrombosis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 18, 2017 Category: Consumer Health News Source Type: news

Newer Blood Thinners May Not Bring Higher Bleeding Risk
WEDNESDAY, Oct. 18, 2017 -- New anti-clotting drugs -- like Xarelto, Pradaxa and Eliquis -- aren't linked with a higher risk of bleeding than the older drug warfarin, a new study finds. Many patients who suffer from blood clots in their legs --... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 18, 2017 Category: General Medicine Source Type: news

In VTE, Bleeding Risk No Higher with Direct Oral Anticoagulants Than Warfarin (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Direct oral anticoagulants do not pose higher risk for major bleeding than warfarin in patients with venous thromboembolism (VTE), according … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 18, 2017 Category: Primary Care Source Type: news

Direct oral anticoagulants as safe as warfarin after VTE
Major bleeding or death no more likely with DOACs than with warfarin in first 90 days ’ treatment Related items fromOnMedica Antidotes for new oral anticoagulants – will they make a difference? Self-managing anticoagulants may cut risks after surgery Extending anticoagulation duration cuts risk of VTE recurrence NOACs instead of warfarin (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 18, 2017 Category: UK Health Source Type: news

CardioBrief: NOACs Not Linked To Excess Bleeding in Real World
(MedPage Today) -- Observational study compares new anticoagulants to warfarin in VTE (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - October 17, 2017 Category: Surgery Source Type: news

You won ’t believe what happened this morning
When I got to the office this morning, several of my employees were in a state of near-panic… I couldn’t imagine what might have happened… and I was alarmed. Turns out, the coffee maker was on the fritz. Coffee is the “drug” of choice for many of the people on my staff. And they’re not alone… An astounding 80% of Americans use the caffeine in coffee to boost their energy. The buzz helps them wake up every morning and gets their day going. And older adults drink coffee more than anyone else. In fact, in a survey by the National Coffee Association, 20% of people over 64 said they ...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

Genetic testing improves blood thinner dosing
Researchers found that genetics-based dosing for the blood thinner warfarin reduces the risk of major side effects in older patients starting the medication. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - October 2, 2017 Category: Consumer Health News Source Type: news

Replacing Warfarin With a Novel Oral Anticoagulant Replacing Warfarin With a Novel Oral Anticoagulant
A good percentage of patients with atrial fibrillation may be ineligible for warfarin due to increased risk of major bleeding or recurrent systemic thromboembolism. Are DOACs a viable alternative?Journal of Cardiovascular Electrophysiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 2, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include aspirin discontinuation risks, HIV in those 50 and older, big data and chronic lung disease, and genetic testing and warfarin use (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 30, 2017 Category: Cardiology Source Type: news

Genetic testing may help determine appropriate dose of warfarin among patients undergoing hip or knee arthroplasty
Findings from a study published online in The Journal of the American Medical Association suggest that, compared to clinically guided dosing, genotype-guided warfarin dosing may reduce the risk of adverse events for joint arthroplasty patients.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - September 30, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

Drug safety update: Miconazole (Daktarin): over-the-counter oral gel contraindicated in patients taking warfarin
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update with advice that patients taking warfarin should not use over-the-counter miconazole oral gel (Daktarin). (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 29, 2017 Category: Drugs & Pharmacology Source Type: news

Genotype-Guided Warfarin Dosing Reduces Adverse Events After Hip, Knee Arthroplasty (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Genotype-guided dosing of warfarin in older adults undergoing elective hip or knee arthroplasty helps prevent adverse events, according to a JAMA study.Roughly … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 27, 2017 Category: Primary Care Source Type: news

Genetic Testing May Help Make Blood Thinner Safer
Dosing adjustments for warfarin can be more precise, researchers say Source: HealthDay Related MedlinePlus Pages: Blood Thinners, Genetic Testing (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 26, 2017 Category: Consumer Health News Source Type: news

Genetic Testing May Help Make Warfarin Safer
TUESDAY, Sept. 26, 2017 -- Genetic testing can improve the safety of the blood thinner warfarin, a new study reports. Warfarin (Coumadin, Jantoven) is often prescribed to prevent life-threatening blood clots in high-risk patients. However, a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 26, 2017 Category: General Medicine Source Type: news

Genotyping Lowers Warfarin Risk in Hip or Knee Replacement Genotyping Lowers Warfarin Risk in Hip or Knee Replacement
Considering variants of three genes that affect response to warfarin improved the safety of using the drug.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 26, 2017 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

CardioBrief: Genotyping Reduces Adverse Eventswith Warfarin
(MedPage Today) -- But still unclear whether benefit justifies the cost (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 26, 2017 Category: Cardiology Source Type: news

CardioBrief: Genotyping Reduces Adverse Events with Warfarin
(MedPage Today) -- But still unclear whether benefit justifies the cost (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - September 26, 2017 Category: Geriatrics Source Type: news

Genetic testing can help determine safest dose of blood thinner
(Hospital for Special Surgery) A new study finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer side effects, in patients having joint replacement surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 26, 2017 Category: International Medicine & Public Health Source Type: news

More Post-endoscopy GI Bleeding With Warfarin Than Direct Oral Anticoagulants More Post-endoscopy GI Bleeding With Warfarin Than Direct Oral Anticoagulants
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 21, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news

Early Anticoagulation Strategies Comparable After Afib-Related Stroke (CME/CE)
(MedPage Today) -- NOAC, warfarin show similar safety and efficacy after mild acute ischemic stroke (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 11, 2017 Category: Cardiology Source Type: news

How Moldy Hay And Sick Cows Led To A Lifesaving Drug
The blood thinner warfarin, which prevents blood clots, owes its existence to some cows who got very sick after eating the wrong hay. That and a chemist who spent years trying to figure out why.(Image credit: Avi Ofer) (Source: NPR Health and Science)
Source: NPR Health and Science - August 29, 2017 Category: Consumer Health News Authors: Joe Palca Source Type: news

Apixaban lowers stroke risk in AF patients undergoing cardioversion (EMANATE)
(European Society of Cardiology) Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-na ï ve patients with atrial fibrillation scheduled for elective cardioversion, according to late-breaking results from the EMANATE trial presented today in a Hot Line LBCT Session at ESC Congress. Rates of bleeding were similar between the two groups. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2017 Category: International Medicine & Public Health Source Type: news

Study: Aspirin Safe for HF Patients (CME/CE)
(MedPage Today) -- Post-hoc WARCEF trial analysis shows no significant risks vs warfarin (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 1, 2017 Category: Cardiology Source Type: news

New Research Supports Safety of Aspirin in Heart Failure
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 1, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news